SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-07 |
| Reported value | $30,933,557 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| TAYSHA GENE THERAPIES INC (TSHA US) | TSHA | COM SHS | $12,099,000 | 3,700,000 |
| FORTE BIOSCIENCES INC (FBRX US) | FBRX | COM NEW | $11,799,705 | 786,647 |
| ALUMIS INC (ALMS US) | ALMS | COM | $5,583,008 | 1,399,250 |
| ZENTALIS PHARMACEUTICALS INC (ZNTL US) | ZNTL | COM | $1,451,844 | 961,486 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.